Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis
CanadaRisk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis
Recalling Firm: Communications and Public Affairs Branch
Grund für den Rückruf / Gefahr
TranslatedProduct safety - New safety information
Produktbeschreibung & Identifikation
TranslatedIf you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1.Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis.Report any health product-related side effects to Health Canada.What healthcare professionals should doInform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction.Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction.Instruct patients to discontinue treatment with glatiramer acetate if they have an anaphylactic reaction.Do not restart the medicine unless there is another clear reason the patient experienced an anaphylactic reaction.
Betroffene Produkte
TranslatedGlatiramer acetate
Additional Source Details
| Field | Value |
|---|---|
| N I D | 77939 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/risk-anaphylactic-reaction-associated-glatiramer-acetate-used-treat-multiple-sclerosis |
| Issue | Product safety - New safety information |
| Title | Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis |
| Product | Glatiramer acetate |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2025-08-21 |
| Organization | Communications and Public Affairs Branch |
| What you should do | If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1.Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis.Report any health product-related side effects to Health Canada.What healthcare professionals should doInform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction.Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction.Instruct patients to discontinue treatment with glatiramer acetate if they have an anaphylactic reaction.Do not restart the medicine unless there is another clear reason the patient experienced an anaphylactic reaction. |
Consumer Action Protocol: What You Should Do Immediately
Safety StepsCheck the model number, serial number, and date stamp on the rating label on the back or underside of the product.
Immediately discontinue using the product. Unplug electrical items and keep juvenile items out of reach of children.
Under statutory consumer protection rules, consumers are entitled to a full refund, certified replacement, or free repair kit without needing the original sales receipt.
If you suffered an injury, illness, or property damage from this product, file an official incident report with regulatory authorities (Health Canada).
Your Legal Rights as a Consumer
Recalls are legally binding corrective safety actions overseen by statutory government bodies. Recalling entities are legally prohibited from charging consumers for official safety remedies. If a retailer or dealership refuses your recall remedy, notify the issuing regulatory agency immediately.
Frequently Asked Questions About This Recall
FAQ GuideQ1:What should I do immediately if I own or bought Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis?
Immediately stop using the product and keep it out of reach of children. Disconnect power if electrical, and do not attempt makeshift home repairs.
Q2:Can I get a full refund or free repair for this recall?
Yes. Recalling manufacturers and retail merchants are required under consumer protection regulations to offer a statutory remedy—typically a full refund, certified repair kit, or replacement unit.
Q3:Do I need my original sales receipt to claim a remedy or refund?
In most recall cases, no receipt is required. Because safety recalls are matters of public health and statutory compliance, retailers and manufacturers routinely issue refunds, store credit, or replacement kits upon presentation of the affected product or lot code.
Q4:Where can I verify official information for this safety alert?
This safety alert is aggregated directly from official regulatory agency records (Health Canada). You can click the 'Official Agency Alert' link on this page to view the primary government notice and contact the manufacturer directly.
Prüfen Sie weitere Produkte in Ihrem Haushalt
Kostenlose ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Übersicht
- Rückrufendes UnternehmenCommunications and Public Affairs Branch
📢 Warnung teilen
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Communications and Public Affairs Branch - Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis Check if your household is affected: https://therecallfile.com/de/recalls/risk-of-anaphylactic-reaction-associated-with-glatiramer-acetate-used/CANADA-77939
Alarm-Liste abonnieren
Erhalten Sie sofortige E-Mail-Benachrichtigungen bei kritischen Produktrückrufen.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Ähnliche Rückrufe
Health CanadaTransport Canada Recall - 2018088 -
Transport Canada Recall - 2018088 -
Tires
Health CanadaTransport Canada Recall - 2018288 -
Transport Canada Recall - 2018288 -
Airbag
Health CanadaTransport Canada Recall - 2018409 -
Transport Canada Recall - 2018409 -
Airbag